SCHEDULE 13G: Khrom Entities Disclose 8.09% Stake in Acadia Healthcare

Khrom Investments Fund, Khrom Capital Management, and Eric Khrom collectively reported an 8.09% beneficial ownership in Acadia Healthcare Company, Inc. as of March 10, 2026.

Summary

• Khrom Investments Fund, LP, Khrom Capital Management LLC, and Eric Khrom (collectively, the "Reporting Persons") have filed a Schedule 13G, disclosing their beneficial ownership in Acadia Healthcare Company, Inc.
• As of March 10, 2026, the Reporting Persons collectively beneficially own 7,457,311 shares of Acadia Healthcare's common stock.
• This aggregate ownership represents approximately 8.09% of the Issuer's outstanding shares, based on 92,211,777 shares outstanding as of February 25, 2026, as reported in the Issuer's Annual Report on Form 10-K.
• Khrom Investments Fund, LP directly owns 7,450,383 shares, over which it has sole voting and dispositive power.
• Eric Khrom directly owns 6,928 shares, over which he has sole voting and dispositive power.
• Khrom Capital Management LLC and Eric Khrom share voting and dispositive power over the 7,450,383 shares directly held by Khrom Investments Fund, LP.
• This Schedule 13G amends previous Schedule 13D filings, indicating a shift to a passive investment stance, with the Reporting Persons certifying that the shares are held in the ordinary course of business and not for influencing control.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant institutional stake (over 8%) by a reputable fund, declared as passive, suggests confidence in the company's value without immediate intentions of disruptive control changes.

Positives

• A significant institutional investor, Khrom Investments Fund, LP, holds a substantial 8.08% stake, indicating strong conviction in Acadia Healthcare's value.
• The filing as a Schedule 13G, rather than a 13D, certifies that the shares are held for ordinary course investment purposes and not for influencing control, which can signal stability and a long-term passive investment approach.

Risks

• The filing itself does not detail risks related to Acadia Healthcare's operations or financial performance, as it is solely a disclosure of beneficial ownership.
• Potential for future changes in ownership by the reporting persons could impact market perception or share liquidity.

Future Outlook

This filing does not provide any forward-looking statements or guidance regarding Acadia Healthcare's future performance or strategic direction, as it is solely an ownership disclosure.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that a significant stake by an investment fund like Khrom Investments in a healthcare company such as Acadia Healthcare often signals a belief in the sector's long-term growth prospects, particularly in behavioral health services. This type of institutional ownership can provide a degree of stability and investor confidence, especially when the investor certifies a passive stance, indicating a belief in the current management and strategy.

Comparison to Industry Standards

• StockSavvy.ai observes that an 8.09% beneficial ownership stake by a single investment group is a substantial position, often placing the investor among the top shareholders. While specific comparable companies or projects are not detailed in this ownership filing, such a significant stake in a publicly traded healthcare provider like Acadia Healthcare is noteworthy.
• For instance, similar large institutional holdings are common in established healthcare providers such as Universal Health Services (UHS) or HCA Healthcare (HCA), where major funds often hold multi-percentage point stakes, reflecting confidence in the underlying business model and market position. This level of ownership by Khrom Investments aligns with typical significant institutional investor positions in the healthcare sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may increase investor confidence and potentially influence trading activity, signaling a notable vote of confidence in the company.
• Management: The passive nature of the investment, as certified in the 13G, suggests no immediate pressure for strategic or operational changes from this specific investor, allowing management to continue executing its current strategy.

Key Dates

Recommendation

A seasoned investor would likely maintain a 'hold' recommendation based solely on this filing. The disclosure of a significant 8.09% passive stake by Khrom Investments Fund indicates institutional confidence in Acadia Healthcare, which is generally a positive signal. However, a 13G filing primarily reports ownership and does not provide new operational or financial performance data to warrant an upgrade or downgrade. The shift from a 13D to a 13G also suggests a less activist stance, reducing potential catalysts for immediate share price appreciation from this investor's actions. Further analysis of the company's fundamentals and market conditions would be required for a more definitive 'buy' or 'sell' recommendation.

Keywords

Acadia Healthcare, AHC, Khrom Investments Fund, Khrom Capital Management, Eric Khrom, Schedule 13G, Beneficial Ownership, Institutional Investor, Healthcare, Common Stock, SEC Filing